Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection

British Journal of Cancer

Volumn 109, Issue 6, 2013, Pages 1609-1617

  Hu, P ^a   Wang, G ^a   Cao, H ^a   Ma, H ^a   Sui, P ^a   Du, J ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CAPILLARY DENSITY; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; ERYTHROCYTE; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LUNG ADENOCARCINOMA; LUNG RESECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; THROMBOCYTE COUNT; TISSUE NECROSIS; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR NECROSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEMOPTYSIS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84884597033     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.485     Document Type: Article

References (29)

1. Arame A, Mordant P, Cazes A, Foucault C, Dujon A, Le Pimpec Barthes F, Riquet M (2012) Characteristics and prognostic value of lymphatic and blood vascular microinvasion in lung cancer. Ann Thorac Surg 94(5): 1673-1679.
2. Dela Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med 32(4): 605-644.
3. Drilon A, Rekhtman N, Ladanyi M, Paik P (2012) Squamous-cell carcinomas of the lung: Emerging biology, controversies, and the promise of targeted therapy. Lancet Oncol 13(10): E418-e426.
4. Fidan A, Ozdogan S, Oruc O, Salepci B, Ocal Z, Caglayan B (2002) Hemoptysis: A retrospective analysis of 108 cases. Respir Med 96(9): 677-680.
5. Friedrichs K, Gluba S, Eidtmann H, Jonat W (2006) Overexpression of p53 and prognosis in breast cancer. Cancer 72(12): 3641-3647.
6. Gazdar AF, Minna JD (1997) Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 89(21): 1563-1565.
7. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V, Sobin L (2007) The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2(8): 706-714.
8. Inoue K, Matsuyama W, Hashiguchi T, Wakimoto J, Hirotsu Y, Kawabata M, Arimura K, Osame M (2001) Expression of vascular endothelial growth factor in pulmonary aspergilloma. Intern Med 40(12): 1195-1199.
9. Kimman M, Norman R, Jan S, Kingston D, Woodward M (2012) The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev 13(2): 411-420.
10. Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, Golshayan A, Rayman PA, Wood L, Garcia J, Dreicer R, Bukowski R, Finke JH (2009) Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res 15(6): 2148-2157.
11. Lakatos E (1988) Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 44(1): 229-241.
12. Lakatos E (2002) Designing complex group sequential survival trials. Stat Med 21(14): 1969-1989.
13. Miller RR, McGregor DH (1980) Hemorrhage from carcinoma of the lung. Cancer 46(1): 200-205.
14. Nichols L, Saunders R, Knollmann FD (2012) Causes of death of patients with lung cancer. Arch Pathol Lab Med 136(12): 1552-1557.
15. Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, Langner C (2010) Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol 41(12): 1749-1757.
16. Reck M, Barlesi F, Crino L, Henschke C, Isla D, Stiebeler S, Spigel D (2012) Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: A consensus report from a panel of experts. Ann Oncol 23(5): 1111-1120.
17. Sandomenico C, Costanzo R, Carillio G, Piccirillo MC, Montanino A, Di Maio M, Rocco G, Normanno N, Perrone F, Morabito A (2012) Bevacizumab in non small cell lung cancer: Development, current status and issues. Curr Med Chem 19(7): 961-971.
18. Shimada Y, Ishii G, Hishida T, Yoshida J, Nishimura M, Nagai K (2010) Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer. J Thorac Oncol 5(7): 970-975.
19. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1): 11-30.
20. Soni MK, Cella D, Masters GA, Burch SP, Heyes A, Silberman C (2002) The validity and clinical utility of symptom monitoring in advanced lung cancer: A literature review. Clin Lung Cancer 4(3): 153-160.
21. Toh B, Abastado J (2012) Tumor-infiltrating granulocytic cells promote cancer cell dissemination. Ecancermedicalscience 6: 241.
22. Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong W-C, Kato M, Prevost-Blondel A, Thiery J-P, Abastado J-P (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 9(9): E1001162.
23. Uzun O, Atasoy Y, Findik S, Atici AG, Erkan L (2009) A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J 4(3): 131-138.
24. Uzun O, Atasoy Y, Findik S, Atici AG, Erkan L (2010) A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J 4(3): 131-138.
25. Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ (2013) MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int J Oncol 42(3): 957-962.
26. Wang Z, Fu J, Diao D, Dang C (2011) Plasma D-dimer level in the perioperative period in non-small-cell lung cancer. Thorac Cancer 2(4): 207-212.
27. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324(1): 1-8.
28. Yano T, Morodomi Y, Ito K, Yoshida T, Haro A, Shoji F, Koga T, Maehara Y (2010) Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. J Thorac Oncol 5(1): 45-48.
29. Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X (2011) Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. J Gastroenterol Hepatol 26(10): 1519-1526.